Robustness of methods for blinded sample size re-estimation with overdispersed count data

被引:13
作者
Schneider, Simon [1 ]
Schmidli, Heinz [2 ]
Friede, Tim [1 ,3 ]
机构
[1] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany
[2] Novartis Pharma AG, Stat Methodol, Basel, Switzerland
[3] DZHK German Ctr Cardiovasc Res, Gottingen, Germany
关键词
event counts; adaptive design; EM algorithm; sample size; clinical trials; ENHANCING LESION COUNTS; ISCHEMIA PILOT ACIP; CLINICAL-TRIALS; MULTIPLE-SCLEROSIS; EXACERBATION RATES; MEDICAL THERAPY; EM ALGORITHM; DESIGN; REVASCULARIZATION; OUTCOMES;
D O I
10.1002/sim.5800
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Counts of events are increasingly common as primary endpoints in randomized clinical trials. With between-patient heterogeneity leading to variances in excess of the mean (referred to as overdispersion), statistical models reflecting this heterogeneity by mixtures of Poisson distributions are frequently employed. Sample size calculation in the planning of such trials requires knowledge on the nuisance parameters, that is, the control (or overall) event rate and the overdispersion parameter. Usually, there is only little prior knowledge regarding these parameters in the design phase resulting in considerable uncertainty regarding the sample size. In this situation internal pilot studies have been found very useful and very recently several blinded procedures for sample size re-estimation have been proposed for overdispersed count data, one of which is based on an EM-algorithm. In this paper we investigate the EM-algorithm based procedure with respect to aspects of their implementation by studying the algorithm's dependence on the choice of convergence criterion and find that the procedure is sensitive to the choice of the stopping criterion in scenarios relevant to clinical practice. We also compare the EM-based procedure to other competing procedures regarding their operating characteristics such as sample size distribution and power. Furthermore, the robustness of these procedures to deviations from the model assumptions is explored. We find that some of the procedures are robust to at least moderate deviations. The results are illustrated using data from the US National Heart, Lung and Blood Institute sponsored Asymptomatic Cardiac Ischemia Pilot study. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:3623 / 3635
页数:13
相关论文
共 37 条
  • [1] The impact of dropouts on the analysis of dose-finding studies with recurrent event data
    Akacha, Mouna
    Benda, Norbert
    [J]. STATISTICS IN MEDICINE, 2010, 29 (15) : 1635 - 1646
  • [2] [Anonymous], 2009, R LANG ENV STAT COMP
  • [3] [Anonymous], 1983, Generalized Linear Models
  • [4] CHMP Committee for Medicinal Products for Human Use, 2007, CHMPEWP245902
  • [5] Sample size reestimation: A review and recommendations
    Chuang-Stein, Christy
    Anderson, Keaven
    Gallo, Paul
    Collins, Sylva
    [J]. DRUG INFORMATION JOURNAL, 2006, 40 (04): : 475 - 484
  • [6] Two-stage design of clinical trials involving recurrent events
    Cook, Richard J.
    Bergeron, Pierre-Jerome
    Boher, Jean-Marie
    Liu, Yang
    [J]. STATISTICS IN MEDICINE, 2009, 28 (21) : 2617 - 2638
  • [7] Asymptomatic cardiac ischemia pilot (ACIP) study two-year follow-up - Outcomes of patients randomized to initial strategies of medical therapy versus revascularization
    Davies, RF
    Goldberg, AD
    Forman, S
    Pepine, CJ
    Knatterud, GL
    Geller, N
    Sopko, G
    Pratt, C
    Deanfield, J
    Conti, CR
    [J]. CIRCULATION, 1997, 95 (08) : 2037 - 2043
  • [8] MAXIMUM LIKELIHOOD FROM INCOMPLETE DATA VIA EM ALGORITHM
    DEMPSTER, AP
    LAIRD, NM
    RUBIN, DB
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-METHODOLOGICAL, 1977, 39 (01): : 1 - 38
  • [9] Food and Drug Administration Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research, 2010, GUID IND AD IN PRESS
  • [10] On the inappropriateness of an EM algorithm based procedure for blinded sample size re-estimation
    Friede, T
    Kieser, M
    [J]. STATISTICS IN MEDICINE, 2002, 21 (02) : 165 - 176